Targeting the SHOC2-RAS interaction in RAS-mutant cancers.
Hauseman ZJ, Stauffer F, Beyer KS, Mollé S, Cavicchioli E, Marchand JR, Fodor M, Viscomi J, Dhembi A, Katz S, Faggion B, Lanter M, Kerr G, Schildknecht D, Handl C, Maddalo D, Pissot Soldermann C, Brady J, Shrestha O, Nguyen Z, Leder L, Cremosnik G, Lopez Romero S, Hassiepen U, Stams T, Linder M, Galli GG, Guthy DA, King DA, Maira SM, Thoma CR, Ehmke V, Tordella L.
Hauseman ZJ, et al.
Nature. 2025 Jun;642(8066):232-241. doi: 10.1038/s41586-025-08931-1. Epub 2025 May 7.
Nature. 2025.
PMID: 40335703
Free PMC article.